As of 2024-07-27, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is 26.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.43 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -16.3%.
The range of the Relative Valuation is 20.54 - 38.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 40.2x - 57.5x | 41.4x |
| Forward P/E multiples | 25.5x - 31.6x | 25.8x |
| Fair Price | 20.54 - 38.48 | 26.30 |
| Upside | -34.7% - 22.4% | -16.3% |
| Date | P/E |
| 2024-07-26 | 61.53 |
| 2024-07-25 | 61.72 |
| 2024-07-24 | 61.51 |
| 2024-07-23 | 61.41 |
| 2024-07-22 | 61.72 |
| 2024-07-19 | 61.35 |
| 2024-07-18 | 61.27 |
| 2024-07-17 | 61.96 |
| 2024-07-16 | 62.13 |
| 2024-07-15 | 58.42 |
| 2024-07-12 | 58.75 |
| 2024-07-11 | 59.92 |
| 2024-07-10 | 57.38 |
| 2024-07-09 | 56.73 |
| 2024-07-08 | 56.16 |
| 2024-07-05 | 56.46 |
| 2024-07-03 | 56.24 |
| 2024-07-02 | 57.14 |
| 2024-07-01 | 56.71 |
| 2024-06-28 | 57.04 |
| 2024-06-27 | 56.28 |
| 2024-06-26 | 55.93 |
| 2024-06-25 | 56.42 |
| 2024-06-24 | 58.40 |
| 2024-06-21 | 57.77 |
| 2024-06-20 | 56.54 |
| 2024-06-18 | 56.77 |
| 2024-06-17 | 56.58 |
| 2024-06-14 | 57.26 |
| 2024-06-13 | 56.48 |
| 2024-06-12 | 56.95 |
| 2024-06-11 | 56.99 |
| 2024-06-10 | 60.00 |
| 2024-06-07 | 60.29 |
| 2024-06-06 | 60.90 |
| 2024-06-05 | 62.17 |
| 2024-06-04 | 61.88 |
| 2024-06-03 | 62.37 |
| 2024-05-31 | 60.49 |
| 2024-05-30 | 60.29 |
| 2024-05-29 | 57.95 |
| 2024-05-28 | 56.52 |
| 2024-05-24 | 55.42 |
| 2024-05-23 | 55.81 |
| 2024-05-22 | 55.05 |
| 2024-05-21 | 53.60 |
| 2024-05-20 | 52.82 |
| 2024-05-17 | 53.91 |
| 2024-05-16 | 53.81 |
| 2024-05-15 | 51.82 |